Short answer
CG Oncology, Inc. (CGON) filed an 8-K current report with the SEC on June 8, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders reelected Christina Rossi and Victor Tong, Jr. as Class II directors through the 2029 annual meeting.
CG Oncology, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders reelected Christina Rossi and Victor Tong, Jr. as Class II directors through the 2029 annual meeting
- Ernst & Young LLP ratified as independent auditor for fiscal year ending December 31, 2026
- Executive compensation approved on advisory basis, with 65,894,959 votes for and 1,603,011 against
- Annual advisory votes on executive compensation selected, with 66,962,791 votes favoring a one-year frequency
- Board continuity and annual say-on-pay votes provide governance stability, while compensation approval signals stockholder support
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CG Oncology, Inc. 8-K filings
Get the next CGON 8-K as it lands
Follow CGON for push alerts, or ask the research agent what this filing means.